Skip to main content
Clinical Trials/NCT04038307
NCT04038307UnknownPhase 2

Pre-emptive Intravenous Paracetamol for Prevention of Intraoperative Shoulder Tip Pain in Patients Undergoing Caesarean Section: A Randomized Double Blind Controlled Clinical Trial.

Cairo University1 site in 1 country120 target enrollmentStarted: August 1, 2019Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 2
Enrollment
120
Locations
1
Primary Endpoint
incidence shoulder tip pain

Study Overview

Brief Summary

the aim is to determine the efficacy of Paracetamol in reducing the incidence and severity of intraoperative shoulder pain in patients undergoing cesarean section.

Detailed Description

pregnant females scheduled for cesarean section under spinal anesthesia will be enrolled . two groups of patents will be recruited . the study group will receive paracetamol pre operative .

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Triple (Participant, Care Provider, Outcomes Assessor)

Eligibility Criteria

Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Healthy pregnant women (ASA II) having singleton pregnancy at term (≤ 37 weeks of gestation) aged between 18 and 40 years.

Exclusion Criteria

  • Patients having allergy to study drug,
  • gestational diabetes
  • cardiovascular or biliary disorders
  • renal impairment
  • preeclampsia
  • any chronic pain condition or trauma in the shoulder, forearms or upper limbs
  • patients with any contraindication to SA were excluded from the study.

Arms & Interventions

control

Placebo Comparator

will receive 100 ml of saline

Intervention: Saline Solution (Drug)

paracetamol group

Experimental

will receive 1gm paracetamol (100ml)

Intervention: paracetamol (Drug)

Outcomes

Primary Outcomes

incidence shoulder tip pain

Time Frame: intraoperative

presence of shoulder tip pain

Secondary Outcomes

  • numerical rating scale(intraoperative)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Yasmin Hassab elnaby

principal investigator

Cairo University

Study Sites (1)

Loading locations...

Similar Trials

Pre-emptive Paracetamol for Prevention of... | Clinical Trial